← Back to Search

Time Restricted Eating + Prebiotic for Obesity

N/A

Recruiting

Led By Kelsey Gabel, PhD

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial aims to use innovative solutions to improve the health of pediatric cancer survivors by exploring the effects of nutrition therapy on weight, body composition, glucose regulation, and cardiovascular risk. It will provide important evidence of the benefits of nutrition therapy for young adult survivors.

Who is the study for?

This trial is for young adult pediatric cancer survivors aged 18-39 with a BMI of 25-39.99 kg/m2 who have completed their anti-tumor treatment. It's not for those with diabetes, severe obesity or underweight, pregnant or breastfeeding women, night shift workers, individuals with certain medical conditions that prevent informed consent or participation in the trial.Check my eligibility

What is being tested?

The study tests time-restricted eating (TRE) alone and TRE combined with a prebiotic fiber supplement to manage weight and improve health outcomes like body composition and cardiovascular risk markers in pediatric cancer survivors.See study design

What are the potential side effects?

Potential side effects are not explicitly listed but may include changes in digestion due to dietary adjustments and prebiotic intake. The safety profile will be closely monitored given the participants' survivorship status.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to TRE

acceptance of TRE in pediatric cancer survivors

feasibility of TRE in pediatric cancer survivors

Secondary outcome measures

Blood pressure

Body composition

Glucagon like peptide 1 concentration

+11 more

Other outcome measures

peripheral blood mononuclear cell (PBMC) telomerase activity

Trial Design

2Treatment groups

Experimental Treatment

Group I: Time restricted eatingExperimental Treatment1 Intervention

Individuals will eat between 12-8pm ad libitum, fasting from 8-12pm.

Group II: TRE+ prebiotic supplementExperimental Treatment1 Intervention

Individuals will eat between 12-8pm ad libitum, fasting from 8-12pn with the addition of a prebiotic fiber supplement with the first eating bout of the day.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

609 Previous Clinical Trials

1,559,279 Total Patients Enrolled

34 Trials studying Obesity

9,823 Patients Enrolled for Obesity

Kelsey Gabel, PhDPrincipal InvestigatorUIC

1 Previous Clinical Trials

17 Total Patients Enrolled

Media Library

Time Restricted Eating Clinical Trial Eligibility Overview. Trial Name: NCT05826184 — N/A

Obesity Research Study Groups: Time restricted eating, TRE+ prebiotic supplement

Obesity Clinical Trial 2023: Time Restricted Eating Highlights & Side Effects. Trial Name: NCT05826184 — N/A

Time Restricted Eating 2023 Treatment Timeline for Medical Study. Trial Name: NCT05826184 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 20 and above being recruited for this experiment?

"The criteria for participation in this research requires that participants are aged between 18 and 39 years old. However, there are a total of 34 clinical trials dedicated to those under the age of eighteen and 81 specifically studied towards seniors over 65."

Answered by AI

May I enroll in this research endeavor?

"Eligibility criteria for this trial states that candidates should be classified as obese, and possess an age between 18 to 39 years old. 45 participants are desired in total."

Answered by AI

Are there current opportunities to participate in this research?

"According to the information hosted on clinicaltrials.gov, this study is no longer actively recruiting patients after being initially posted on June 1st 2023 and edited most recently on April 21st of the same year. Although recruitment has stopped for this trial, there are currently 152 other studies that need volunteers."

Answered by AI

What aims are researchers attempting to achieve through this study?

"This medical experiment, which will be monitored for approximately a year's time, has the primary objective of assessing uptake of TRE amongst young cancer survivors. In addition to this goal, there are secondary outcomes related to body composition (fat free mass and fat mass via DXA), fasting insulin levels (measured by enzymatic kit in uIU/ml^4), as well as fasting glucose levels (measured by an enzymatic kit in mg/dl)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Time Restricted Eating With or Without a Fiber Supplement for Weight Management in Pediatric Cancer Survivors

Kelsey Nicole Dipman Gabel 2023. "Time Restricted Eating With or Without a Fiber Supplement for Weight Management in Pediatric Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05826184.

All > Pediatric Cancer